-
Most Popular
![Healthcare Stocks Icon](https://investorplace.com/wp-content/uploads/2022/12/healthcare-150x150.png)
Healthcare Stocks
Healthcare encompasses a wide range of organized services to prevent, treat, and diagnose medical needs and mental illnesses. The $336 billion market is expected to grow at a compound annual growth rate of 8% until 2030, demonstrating the necessity of adequate healthcare. Healthcare companies, ranging from retailer CVS to insurance giant UnitedHealth, provide these services to a massive customer base.
![The words "recession proof" written on a pink sticky note. bulletproof stocks](https://investorplace.com/wp-content/uploads/2023/07/shutterstock_2170602547-150x150.jpg)
7 Recession-Resistant Stocks to Hold Onto for Dear Life in 2024
These seven recession-resistant stocks offer stability and potential growth even in challenging economic conditions.
![Interest rate and dividend concept. Businessman with percentage symbol and up arrow, Interest rates continue to increase, return on stocks and mutual funds, long term investment for retirement. Dividend stocks](https://investorplace.com/wp-content/uploads/2024/06/dividend-stocks1600-5-150x150.png)
7 Dependable Dividend Stocks for Long-Term Income
Explore the best dividend stocks for long-term income excelling in the healthcare, retail, tobacco and home improvement markets.
![medicine research, pharmaceutical background, LJPC stock](https://investorplace.com/wp-content/uploads/2022/03/pharmaceuticals_tnxp_1600-150x150.png)
3 Pharmaceutical Stocks That Can Surge Higher Even if The Markets Correct
These are the pharmaceutical stocks to buy as they represent undervalued companies with a deep clinical pipeline that will support growth.
Recent Healthcare Stocks Articles
Exit Alert: 3 Stocks to Offload Before the Downturn
Discover why three top stocks to sell now are facing challenges in technology hardware, pharmaceuticals and automobile manufacturers.
TEM Stock IPO: 7 Things to Know as Tempus AI Starts Trading Today
Tempus AI begins trading today on the Nasdaq and is valued at $6 billion. Here's what to know about the new TEM stock.
Why Is Bio-Path (BPTH) Stock Up 20% Today?
Bio-Path stock is up on Friday with heavy trading of NPTH shares after the company posited positive interim data from a Phase 2 study.
Why Is Gain Therapeutics (GANX) Stock Down 25% Today?
Gain Therapeutics stock is down on Friday after the company priced an $11 million public offering for roughly 7 million shares of GANX.
Why Is Nexalin Technology (NXL) Stock Down 29% Today?
Nexalin Technology stock is down on Friday after shares of NXL rallied yesterday alongside approval for its neurostimulation device.
Why Is Foxo Technologies (FOXO) Stock Up 55% Today?
Foxo Technologies stock is up on Friday with heavy trading after the company announced to acquisition deals with Rennova Health.
Medical Debt Hurting Your Credit Score? How Biden’s New Plan Could Fix That
Let's dive into a new plan from the Biden Administration aimed at helping those with credit score issues and medical debt navigate the system.
Why Is Sharps Technology (STSS) Stock Up 21% Today?
Sharps Technology stock is up on Thursday with heavy trading of STSS shares after the company signed a $30 million purchase order.
Why Is BioRestorative Therapies (BRTX) Stock Up 42% Today?
BioRestorative Therapies stock is up on Thursday with heavy trading of BRTX shares after announcing licensing negotiations.
Why Is Cara Therapeutics (CARA) Stock Down 27% Today?
Cara Therapeutics stock is down on Thursday as investors learn of a failed clinical trial and the company considering strategic alternatives.